Consequences of Hyperphosphatemia:
Are We Accepting the Unacceptable?
University of Minnesota
CME Internet Program
Evaluation Form
Thank you for participating in the Internet program "Consequences of Hyperphosphatemia: Are We Accepting the Unacceptable?" sponsored by the University of Minnesota Medical School Office of Continuing Medical Education.
To earn CME credits, print this form, using File Print or the Print button on your browser menu, along with the enrollment and posttest forms. Complete these forms (indicating your answers directly on the printed sheet) and mail them to:
University of Minnesota
Office of Continuing Medical Education
615 Washington Ave. SE
Suite 107
Minneapolis, MN 55414or FAX to (612) 626-7766.
Forms must be received by March 31, 2001 to earn credits.
A = Excellent B = Good C = Average D = Poor E = Very Poor
The scope of coverage was A B C D E The depth of coverage was A B C D E Potential clinical application is A B C D E Consistency with learning objectives was A B C D E Fair consideration of all viable therapeutic alternatives A B C D E My overall reaction was A B C D E Phospate in Pathogenesis of Secondary HyperPTH (Slatopolsky) A B C D E Acid-Base and the Skeleton (Bushinsky) A B C D E Epidiomolgy and Quality Improvement (Chertow) A B C D E Have you ever used a noncalcium-non-aluminum phosphate binder?
(A) yes (B) noA B Rank the following in terms of importance: (A = most, E = least) - Dialysis adequacy A B C D E - Hyperphosphatemia/calcification A B C D E - Nutrition A B C D E - Anemia management A B C D E - Blood pressure A B C D E What are the most important aspects of new phosphate binder? (A = most, E = least) - Low risk of side effects (hypercalcemia, toxicity) A B C D E - Independent control of calcium and phosphorus A B C D E - Long-term efficacy A B C D E - Cost A B C D E - Long-term benefits for cardiac, bone and parathyroid health A B C D E - Other, please list A B C D E
What is your general opinion of these therapies?
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
What do you think an optimal Ca x P product is for your patients?
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
What Ca x P target do you think is achievable?
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
Indicate any changes in your practice you intent to make as a result of this program.
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
What other information/seminars would be of interest to you and your colleauges?
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
Other comments:
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
Go to CME Internet Course Description
Go to Enrollment form
Go to Posttest